Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2022 | Story Lacea Loader

From 24 February 2022 – as an interim solution to the challenges experienced with the disruption of classes on the University of the Free State (UFS) Bloemfontein Campus during the week of 21 February 2022 – the academic programme will continue in a differentiated and flexible online mode in some modules within faculties.

Face-to-face classes will continue in those modules where online teaching is not possible at this stage. Students will be informed by their respective faculties as to which modules will be moving online, and which will remain face to face.

This is a temporary measure to enable the campus to return to stability. The arrangement is estimated to continue for two to three weeks at the most, after which the academic programme will return to the approved teaching plans for 2022.

As an additional measure and to mitigate the challenges of remote off-campus internet access, 10 GB of data is provided free of charge through Global Protect to all registered students for the next month. This will enable students to link to learning resources off campus at no cost. The use of social media is, however, not included in the 10 GB.

Enquiries regarding GlobalProtect can be directed to the ICT Services Call Centre at +27 51 401 9111 (option 4).

Computer laboratories on the campus will remain available to vaccinated students whose modules will be moving online.

Issued by:
Lacea Loader
Director: Communication and Marketing
University of the Free State
loaderl@ufs.ac.za

23 February 2022

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept